AbbVie's competitors

AbbVie's competitors include GlaxoSmithKline, Johnson & Johnson, Novartis, MyoKardia and Roche
Add company...
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Roche
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market.
Founding Date
Founding Date
2013
Founding Date
2001
Founding Date
1886
Founding Date
1996
Founding Date
N/A
Founding Date
1896
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
North Chicago, US HQ
Locations
Brentford, GB HQ
Tirana, AL
Boudouaou Est, DZ
Buenos Aires, AR
Yerevan, AM
Sydney, AU
Boronia, AU
see more
Locations
New Brunswick, US HQ
Dhaka, BD
Machelen, BE
Suzhou, CN
New Delhi, IN
see more
Locations
Basel, CH HQ
Beijing, CN
Wehr, DE
Tokyo, JP
East Hanover, US
New York, US
Locations
South San Francisco, US HQ
Locations
Basel, CH HQ
South San Francisco, US
Employees
Employees
30,000
Employees
99,827 1% increase
Employees
126,400
Employees
121,000 2% increase
Employees
98
Employees
94,052
Valuation ($)
Valuation ($)
190.1 b
Valuation ($)
89 b
Valuation ($)
364.5 b
Valuation ($)
175.5 b
Valuation ($)
1.9 b
Valuation ($)
N/A
Facebook followers
Facebook followers
11.7 k
Facebook followers
269.3 k
Facebook followers
775.6 k
Facebook followers
285.9 k
Facebook followers
N/A
Facebook followers
77.9 k
Twitter followers
Twitter followers
47.6 k
Twitter followers
160.9 k
Twitter followers
88.9 k
Twitter followers
232 k
Twitter followers
370
Twitter followers
175 k

Financial

Revenue (est.)
Revenue (est.)
$25.6b (FY, 2016)
Revenue (est.)
£27.9b (FY, 2016)
Revenue (est.)
$71.9b (FY, 2017)
Revenue (est.)
$48.5b (FY, 2016)
Revenue (est.)
$39.2m (FY, 2016)
Revenue (est.)
Fr.48.1b (FY, 2015)
Cost of goods
Cost of goods
$5.8b (FY, 2016)
Cost of goods
£9.3b (FY, 2016)
Cost of goods
$21.7b (FY, 2017)
Cost of goods
$17.5b (FY, 2016)
Cost of goods
N/A
Cost of goods
Fr.15.5b (FY, 2015)
Gross profit
Gross profit
$19.8b (FY, 2016)
Gross profit
£18.6b (FY, 2016)
Gross profit
$50.2b (FY, 2017)
Gross profit
$31b (FY, 2016)
Gross profit
N/A
Gross profit
Fr.32.7b (FY, 2015)
Net income
Net income
$6b (FY, 2016)
Net income
£1.1b (FY, 2016)
Net income
$16.5b (FY, 2017)
Net income
$6.7b (FY, 2016)
Net income
($13.2m) (FY, 2016)
Net income
Fr.9.1b (FY, 2015)

Operating

Countries
Countries
N/A
Countries
100 (FY, 2017)
Countries
60 (FY, 2016)
Countries
N/A
Countries
N/A
Countries
N/A
Drugs Approved by FDA
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (FY, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
16 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
12 (Y, 2016)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
87 (FY, 2017)
Manufacturing Facilities
119 (FY, 2016)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles